Perfluorocarbon gel formulations

Details for Australian Patent Application No. 2009322989 (hide)

Owner Oxygen Biotherapeutics, Inc.

Inventors Huvard, Gary; Kiral, Richard; Quitaro, Maxine; Thompson, Deborah P.; Grossman, Aharon; Clauson, Gary; Sandhu, Gurbhagat; Klein, Gerald

Agent Baldwins

Pub. Number AU-A-2009322989

PCT Pub. Number WO2010/065059

Priority 12/589,202 19.10.09 US; 61/200,254 25.11.08 US; 61/204,785 09.01.09 US; 61/205,499 21.01.09 US

Filing date 17 November 2009

Wipo publication date 10 June 2010

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065059 Priority application(s): WO2010/065059

1 September 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Jul 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322999-Compositions comprising reninangiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of reninangiotensin aldosterone system related disorders

2009322983-Production of polyhydroxyalkanoate foam